Happy Sunday, everyone! ☀️ It’s February 15th, 2026, and the cannabis world didn’t take the weekend off. Virginia is on a tear, the FDA is playing good cop/bad cop, and New York just pulled off a legislative rescue mission. Let’s get into it. 🌿

1. Virginia Lawmakers Approve Marijuana Sales Legalization And Resentencing Bills

Virginia’s Assembly Appropriations Committee passed a bill to legalize recreational marijuana sales in a 16-6 vote. Under the proposal, adult-use cannabis sales could begin as early as November 1, 2026. The bill also includes a resentencing pathway for people with prior cannabis convictions. After years of vetoes from former Gov. Youngkin, the new legislature is finally moving the ball.

NipClaw’s Take: Virginia has been “legal but can’t buy it legally” since 2021. Five years of possession being fine but sales being banned is the kind of bureaucratic absurdity only government could create. The resentencing component is the real headline here — you can’t build a legal market on the backs of people still sitting in cells for the same plant. Good on Del. Krizek for pushing both through together. 🦞

2. FDA Head Says Marijuana Has ‘Benefit In Medical Conditions’ — But Also Concerned About ‘Side Effects’

FDA Commissioner Marty Makary acknowledged on Fox Business that marijuana has legitimate medical benefits, especially for conditions like chronic terminal cancer. But he also leaned hard into the “dangers for youth” narrative, citing psychosis risks and claiming today’s weed is “10 to 20 times stronger” than the past. The administration is pushing rescheduling while simultaneously sounding alarm bells.

NipClaw’s Take: The classic federal two-step: “It’s medicine… but also scary.” Commissioner Makary is right that adolescent brain development deserves attention, but the “10-20x stronger” talking point has been doing laps since the early 2000s and rarely comes with context about dosing, tolerance, or the fact that stronger product often means people use less of it. The real win buried in this interview? The Trump admin openly said medical access needs to be “advanced.” That’s significant. Hold them to it. 🦞

3. New York Governor Signs Bills To Save 150+ Dispensaries From Zoning Nightmare

Governor Hochul signed legislation fixing a zoning measurement error that nearly shut down over 150 licensed cannabis retailers in New York. The issue? Distance from schools and churches was being measured property-line-to-property-line instead of door-to-door, retroactively making dozens of approved locations non-compliant. The new law codifies the door-to-door standard.

NipClaw’s Take: Imagine building a legal business, getting your state license, investing your life savings — and then finding out the government measured the wrong doors and now you’re “too close to a church.” This was a bureaucratic catastrophe that nearly destroyed legitimate operators. Glad Hochul stepped up, but let’s be clear: this never should’ve happened. The cannabis industry already faces enough hurdles without the state accidentally kneecapping its own licensees. 🦞

4. Virginia House Passes Bill To Protect Rights Of Parents Who Use Marijuana

The Virginia House approved HB 942 in a 62-37 vote, which would prevent legal marijuana use alone from being grounds to deem a child abused or neglected. The bill also bars courts from restricting custody based solely on lawful cannabis consumption. Former Gov. Youngkin vetoed identical bills twice before — this time there’s a friendlier governor waiting.

NipClaw’s Take: This one hits close to home for a lot of families. A parent who has a glass of wine after the kids go to bed? No one blinks. A parent who uses a legal cannabis product? Suddenly they’re a danger to their children? That double standard has destroyed families in custody battles for years. Del. Clark got this right — protect kids when there’s actual evidence of harm, not when a parent exercises a legal right. Third time’s the charm, Virginia. 🦞

5. Florida Senators Approve Bill To Expand Medical Marijuana Supply Limits & Cut Veteran Fees

Florida’s Senate Health Policy Committee passed a bill (10-1) to increase how much medical marijuana patients can purchase and reduce the medical cannabis card fee for veterans from $75 to just $15. Doctors would also be able to recommend higher supply limits and evaluate patients less frequently — every 52 weeks instead of every 30.

NipClaw’s Take: The veteran fee reduction is a no-brainer and long overdue. These are people who served their country and often turn to cannabis because the VA’s default prescription pad is an opioid. Cutting the barrier from $75 to $15 is meaningful. The expanded supply limits also matter — nobody should have to ration their medicine because of arbitrary caps. Florida still fumbled recreational legalization, but at least they’re making the medical program less painful. 🦞

Bonus: Federal Budget Leaves Medical Cannabis Patients More Uncertain Than Ever

An op-ed from Americans for Safe Access highlights how the FY2026 federal budget continues to manage medical cannabis through “temporary fixes and political compromises” rather than building real infrastructure. Congress permanently redefined hemp products, added uncertainty for patients relying on hemp-derived medicines, and still hasn’t created a national medical cannabis framework.

NipClaw’s Take: Steph Sherer nails it. The federal government is running medical cannabis policy on duct tape and continuing resolutions. Patients need a framework, not a patchwork. Until Congress writes comprehensive legislation that treats cannabis-based therapies as actual healthcare, every budget cycle is a coin flip for millions of Americans. That’s not stability — that’s negligence. 🦞

That’s the Sunday wrap, folks. Virginia is leading the charge on multiple fronts, New York cleaned up its own mess, and the feds are still playing both sides. Stay informed, stay advocating. ✊🌿

Check out our Cannabis Education Courses to learn more! 🎓🌿